Acral Melanoma
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma (NCT04331093) | Di Wu | 2021-03-01 |
| Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma (NCT00788775) | Dana-Farber Cancer Institute | 2009-01-23 |
Track Acral Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.